Leela Barham, Author at Pharmaphorum

About Leela Barham

Access to new medicines in Scotland: a perennial issue

https://pharmaphorum.com/views-and-analysis/access-to-new-medicines-in-scotland-a-perennial-issue/

Mandatory or voluntary? A sticking point for European HTA

https://pharmaphorum.com/views-analysis-market-access/mandatory-or-voluntary-a-sticking-point-for-european-hta/

Late to the party but we brought friends: BeneLuxA’s horizon scanning initiative

https://pharmaphorum.com/views-analysis-market-access/joint-horizon-scanning/

A payer’s perspective on value-based contracting (VBC)

https://pharmaphorum.com/views-analysis-market-access/payers-perspective-value-based-contracting-vbc/

Paying for value: US state of play

https://pharmaphorum.com/views-analysis-market-access/us-value-based-payment-models/

Division on European HTA

https://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/

Who should pay for HTA?

https://pharmaphorum.com/views-analysis-digital/who-should-pay-hta/

Harmonised health technology assessment in Europe? There’s a long way to go

https://pharmaphorum.com/views-analysis-market-access/harmonised-health-technology-assessment-in-europe-theres-a-long-way-to-go/

‘Free’ pricing in the UK: the influence of NICE and NHS England

https://pharmaphorum.com/views-and-analysis/pas-free-pricing-uk-nice-nhs-england/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com